Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citra Buana Prasida Tbk. (CBPE) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Citra Buana Prasida Tbk.Trade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Citra Buana Prasida Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Citra Buana Prasida Tbk. trades at Rp282 (market cap 385.18B, 10.2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Citra Buana Prasida Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 10.2K). Which is the better fit depends on your goals.

CBPEDGNS
Market Cap
385.18B310.75B
Volume
10.2K963.6K
Lot
1029.64K
Turnover
2.9M217.67M
Average Price
283.88225.89
Value
2.9M217.67M
Indicative Equilibrium Price
226
Indicative Equilibrium Volume
1K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CBPE
View details
DGNS
View details

About Citra Buana Prasida Tbk.

PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.

Read more on CBPE

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS